Non-myotonic dystrophy

Non-myotonic dystrophy

To participate in this study, contact: Merrilee Needham

Research site: Royal North Shore Hospital, Sydney

In collaboration with Frank Mastaglia and Chris Blundell, WA

Necrotizing autoimmune myopathy (NAM) is a treatable disease – patients respond to                            immunosuppressive agents such as prednisone.

Statins have been associated with necrotising myopathies and is strengthened by the discovery that the serum of some patients contains an anti-HMGCR antibody.

Patients on statins with necrotising myopathy are needed for further studies in this area.

  • Longitudinal studies – registries
  • Management of cardiac complications
  • Cognitive impairment
  • Management of fatigue and sleep disturbance
  • Susceptibility to infection